Axsome Therapeutics
AXSM
AXSM
176 hedge funds and large institutions have $1.51B invested in Axsome Therapeutics in 2021 Q2 according to their latest regulatory filings, with 24 funds opening new positions, 67 increasing their positions, 50 reducing their positions, and 31 closing their positions.
Holders
176
Holders Change
-8
Holders Change %
-4.35%
% of All Funds
3.07%
Holding in Top 10
3
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.05%
New
24
Increased
67
Reduced
50
Closed
31
Calls
$28.4M
Puts
$60.4M
Net Calls
-$32M
Net Calls Change
+$7.45M
Top Buyers
| 1 |
PA
1
Perceptive Advisors
New York
|
$37.4M |
| 2 |
BG
2
Bellevue Group
Kuesnacht,
Switzerland
|
$23.7M |
| 3 |
3
Morgan Stanley
New York
|
$21.4M |
| 4 |
4
Citadel Advisors
Miami,
Florida
|
$38.4M |
| 5 |
5
Nuveen Asset Management
Chicago,
Illinois
|
$44.4M |
